Is Bloom Energy A Scam?
Summary
DumbMoney addresses the recent 20% decline in Bloom Energy's stock following a short seller's comparison of the company to Theranos on CNBC. The core of the controversy involves claims that Bloom lacks sufficient scandium to power its fuel cell technology. DumbMoney contends that these allegations are not new and notes that Bloom recently clarified in an SEC filing that it possesses enough non-China scandium for its current backlog and visibility into 25 gigawatts of annual production.
DumbMoney emphasizes the importance of institutional validation, pointing to massive deals with Oracle, Brookfield, and Nebius. DumbMoney argues that these sophisticated corporations would not stake their AI infrastructure on Bloom without verifying the supply chain. Furthermore, DumbMoney points out that short sellers do not have access to Bloom's proprietary manufacturing yields and efficiency gains, which are critical for accurately calculating material requirements.
Mentioned Stocks
Reasoning: DumbMoney argues that the short seller's claims about scandium shortages are speculative because they lack access to Bloom’s proprietary efficiency data. DumbMoney emphasizes that major partners like Oracle and Brookfield have committed billions, which implies they verified the supply chain during due diligence. Additionally, DumbMoney views the 20% price drop as an opportunity, noting that sector-wide data center delays are being unfairly used as a specific critique of Bloom.